Regeneron Pharmaceuticals (REGN) Asset Utilization Ratio (2010 - 2026)
Regeneron Pharmaceuticals' quarterly Asset Utilization Ratio came in at 0.37 in Q1 2026, down 2.04% year-on-year from 0.37 in Q1 2025, and up 3.13% quarter-over-quarter from 0.36 in Q4 2025.
Regeneron Pharmaceuticals has reported Asset Utilization Ratio for 17 years, with the latest figure at 0.37 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio fell 2.04% year-over-year to 0.37; the trailing twelve-month figure through Mar 2026 stood at 0.37 (down 2.04% YoY), and the FY2025 full-year result was 0.37, down 8.65% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.37, up from 0.36 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.52 in Q1 2022, with the low at 0.21 in Q4 2022.
- Average Asset Utilization Ratio over 5 years is 0.37, with a median of 0.38 recorded in 2025.
- Year-over-year, Asset Utilization Ratio slumped 68.08% in 2022 and jumped 92.45% in 2023.
- Tracing REGN's Asset Utilization Ratio over 5 years: stood at 0.21 in 2022, then jumped by 92.45% to 0.4 in 2023, then decreased by 6.07% to 0.38 in 2024, then dropped by 5.92% to 0.36 in 2025, then grew by 3.13% to 0.37 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.37 (Q1 2026), 0.36 (Q4 2025), and 0.36 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.85 |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.37 |
| Dec 31, 2025 | 0.36 |
| Sep 30, 2025 | 0.36 |
| Jun 30, 2025 | 0.38 |
| Mar 31, 2025 | 0.37 |
| Dec 31, 2024 | 0.38 |
| Sep 30, 2024 | 0.38 |
| Jun 30, 2024 | 0.38 |
| Mar 31, 2024 | 0.39 |
| Dec 31, 2023 | 0.40 |
| Sep 30, 2023 | 0.31 |
| Jun 30, 2023 | 0.31 |
| Mar 31, 2023 | 0.31 |
| Dec 31, 2022 | 0.21 |
| Sep 30, 2022 | 0.39 |
| Jun 30, 2022 | 0.42 |
| Mar 31, 2022 | 0.52 |
| Dec 31, 2021 | 0.65 |
| Sep 30, 2021 | 0.60 |
| Jun 30, 2021 | 0.63 |
| Mar 31, 2021 | 0.53 |
| Dec 31, 2020 | 0.51 |
| Sep 30, 2020 | 0.52 |
| Jun 30, 2020 | 0.49 |
| Mar 31, 2020 | 0.46 |
| Dec 31, 2019 | 0.46 |
| Sep 30, 2019 | 0.49 |
| Jun 30, 2019 | 0.50 |
| Mar 31, 2019 | 0.53 |
| Dec 31, 2018 | 0.60 |
| Sep 30, 2018 | 0.61 |
| Jun 30, 2018 | 0.64 |
| Mar 31, 2018 | 0.67 |
| Dec 31, 2017 | 0.67 |
| Sep 30, 2017 | 0.66 |
| Jun 30, 2017 | 0.66 |
| Mar 31, 2017 | 0.67 |
| Dec 31, 2016 | 0.70 |
| Sep 30, 2016 | 0.73 |
| Jun 30, 2016 | 0.77 |
| Mar 31, 2016 | 0.77 |
| Dec 31, 2015 | 0.76 |
| Sep 30, 2015 | 0.78 |
| Jun 30, 2015 | 0.78 |
| Mar 31, 2015 | 0.76 |
| Dec 31, 2014 | 0.74 |
| Sep 30, 2014 | 0.73 |
| Jun 30, 2014 | 0.74 |
| Mar 31, 2014 | 0.74 |
| Dec 31, 2013 | 0.75 |
| Sep 30, 2013 | 0.76 |
| Jun 30, 2013 | 0.75 |
| Mar 31, 2013 | 0.73 |
| Dec 31, 2012 | 0.74 |
| Sep 30, 2012 | 0.70 |
| Jun 30, 2012 | 0.54 |
| Mar 31, 2012 | 0.42 |
| Dec 31, 2011 | 0.39 |
| Sep 30, 2011 | 0.31 |
| Jun 30, 2011 | 0.20 |
| Mar 31, 2011 | 0.20 |
| Dec 31, 2010 | 0.11 |
| Sep 30, 2010 | 0.16 |